news & events
ysios news
23.03.17
BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital
20.03.17
MedLumics Secures 34.4 Million Euros in Series B Funding
08.02.17
Prexton Therapeutics Series B financing round raises EUR 29 million (USD 31 million) to advance its novel Parkinson’s therapeutic
30.11.16
OxThera raises EUR 32 million to complete development of Oxabact® for treatment of Primary hyperoxaluria
04.11.16
CorWave Raises $17.1 Million in Series B Financing
18.10.16
Ysios capital raises €126,4 m ($140 m) for its second fund, Ysios Biofund II Innvierte
10.08.16
CVRx® Secures $113 Million in New Financing
14.04.16
Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing
11.04.16
STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare
09.03.16
”la Caixa” leads an investment round in Inbiomotion with the participation of Ysios Capital
